SPONSORED CONTENT -- (StatePoint) Forty-two percent of women experience sexual dysfunction -- and Hypoactive Sexual Desire Disorder (HSDD) -- characterized as frustrating low libido, is the most common form of it. It is estimated that about one in 10 women have this condition.
The good news? Low sex drive in women can be treated. Clinically proven options are helping hundreds of thousands of women address HSDD. In fact, as of May 2025, over 25,000 healthcare providers are prescribing Addyi, a particularly effective hormone-free drug sometimes referred to as “female Viagra” or “the little pink pill.” Here are five facts to know about HSDD and how medication can help treat it:
1. HSDD is caused by an imbalance of chemicals in the brain and its effects can extend well beyond the bedroom. HSDD can also cause feelings of frustration and create tension in relationships.
2. For the last 10 years, Addyi has been the number one prescribed treatment for HSDD in women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.
3. While many prescription drugs are unaffordable, Addyi is often covered by insurance and can cost as low as $20 a month.
4. Addyi is well-tested. Sprout Pharmaceuticals conducted the largest ever clinical trials in women’s health for its FDA filing, submitting evidence from over 13,000 patients, three times as much data as any male sexual health drug. In pooled data from three pivotal trials, Addyi significantly outperformed the placebo across all six Female Sexual Function Index domains: orgasm, lubrication, arousal, desire, satisfaction, pain reduction, as well as met all measurements of effectiveness required by the FDA with statistical significance. The results:
• 50% increase in desire for sex
• 75% increase in satisfaction with sexual events
• 50% reduction in the stress women struggling with HSDD feel
5. Wide-ranging organizations see the value of this medication for women’s health and well-being and supported its FDA approval, including The National Council of Women’s Organizations, the Black Women’s Health Imperative, the Association of Reproductive Health Professionals, National Consumers League, and the American Sexual Health Association.
You can find out if you’re a good candidate for treating HSDD with medication by bringing it up with your existing healthcare professional. To find a provider in your area, to learn more, or to access Addyi via telehealth, visit https://addyi.com.
“Living with HSDD can be challenging. Fortunately, the regulations around drugs that can help women address their concerns around sexual function have caught up with the need,” says Cindy Eckert, founder and CEO of Addyi.
Photo Credit: (c) PeopleImages / iStock via Getty Images Plus
